DSpace logo

Please use this identifier to cite or link to this item: http://142.54.178.187:9060/xmlui/handle/123456789/12233
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAhmed, M. Maqbool-
dc.contributor.authorTodehdehghan, F-
dc.contributor.authorBaig, Shahid-
dc.date.accessioned2021-01-19T09:26:03Z-
dc.date.available2021-01-19T09:26:03Z-
dc.date.issued1989-07-01-
dc.identifier.urihttp://142.54.178.187:9060/xmlui/handle/123456789/12233-
dc.description.abstractBlood glucose, serum bilirubin, serum enzymes, i.e. SAP, SGPT and SGOT, sodium and potassium, LH, FSH and estradiol level were determined in 93 women (aged 25-45). These subjects were grouped according to the time of receiving intragluteal injections (200 mg NETEN 8-weeks intervals). The groups of women receiving injections for 19-24 months showed a significant decrease (P < 0.01) in LH, FSH and estradiol levels. The pregnancy rate was 2%. Levels of LH, FSH and estradiol were elevated in women receiving injections for 25-38 months. The pregnancy rate was 3%. 17,e values were not significantly different when compared with controls. A significant increase in serum bilirubin, SAP, SGPT, SGOT, sodium and potassium levels were recorded in all treated groups. 17,e control and treated groups did not show any significant difference with respect to blood glucose levels.en_US
dc.language.isoenen_US
dc.publisherPakistan Journal of Medical Researchen_US
dc.relation.ispartofseriesVol. 28;No.3-
dc.titleSerum LH, FSH and Estradiol Levels in Women Using Injectable Contraceptive (Norigest) Over Long Periods of Timeen_US
dc.typeArticleen_US
Appears in Collections:Articles

Files in This Item:
File Description SizeFormat 
1.pdf4.42 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.